Moloney Securities Asset Management’s AbCellera Biologics ABCL Stock Holding History

Moloney Securities Asset Management’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$41.2K	Sell
2025 Q1	$32.1K	Sell
2024 Q4	$265K	Buy
2022 Q3	–	Sell
2022 Q2	$168K	Buy
2022 Q1	–	Sell
2021 Q4	$187K	Sell
2021 Q3	$443K	Buy
2021 Q2	$240K	Sell
2021 Q1	$1.05M	Buy